elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Pricing
Log in
Sign up
Home
/
Subjects
/
CD20
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
CD20
RIS
0.002
(Research Intensity Score)
Papers
357
Top papers
Ofatumumab versus Teriflunomide in Multiple Sclerosis
2020 · 708 citations
Effects of cadmium stress on growth and physiological characteristics of sassafras seedlings
2021 · 281 citations
Sequential antigen loss and branching evolution in lymphoma after CD19- and CD20-targeted T-cell–redirecting therapy
2024 · 61 citations
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy
2020 · 395 citations
The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function
2025 · 26 citations
Role of Fcγ receptors in HER2-targeted breast cancer therapy
2022 · 123 citations
IgG4-Mediated Neurologic Autoimmunities
2021 · 99 citations
Targeted immunotherapies for Graves’ thyroidal & orbital diseases
2025 · 15 citations
Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond
2024 · 17 citations
Newest papers
Severe Central Nervous System Fungal Infection Following Tirabrutinib Administration in a Patient with Refractory Primary Central Nervous System Lymphoma: A Case Report
2026
Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial
2026
Functional Characteristics Derived from the Structural Design of Bispecific Antibodies
2026
Immunogenomic Characterization of Triple-Negative Breast Cancer in a Moroccan Cohort and Its Prognostic Implication
2026
Evaluation of the humoral response during ocrelizumab therapy in multiple sclerosis — an observational study
2026
Age-independent immune subtypes in type 1 diabetes exhibit distinct post-onset progression rates and immunotherapeutic responses
2026
κ-index as a potential prognostic biomarker of disease activity in multiple sclerosis
2026
Radiometabolic Therapy in Lymphoma: From Radioimmunotherapy to Emerging Theranostic and Combination Strategies
2026
CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma
2026
Browse all papers →
CD20's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
CD20's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link